Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAND Trial of Sativex for agitation and aggression in Alzheimer's disease care home residents
ISRCTN97163562Phase 2Completed
- Sponsor
- King's College London
- Start
- Aug 2021
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Treatment as usual + placebo with Treatment as usual + Sativex (2 arms). Primary endpoints: Number of participants recruited, Number of participants followed up and 1 more. Started Aug 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on ISRCTN97163562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN97163562.